Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

South African HIV-1 vaccine candidates - the journey from the bench to clinical trials.

Williamson AL, Rybiki E, Shephard E, Gray G, Bekker LG, Downing K, Williamson C.

S Afr Med J. 2012 Mar 2;102(6):452-5.

PMID:
22668934
2.
4.
5.

HIV vaccines: a global perspective.

Esparza J, Osmanov S.

Curr Mol Med. 2003 May;3(3):183-93. Review.

PMID:
12699356
7.

HIV vaccine development: past, present and future.

Robb ML.

IDrugs. 2010 Dec;13(12):852-6. Review.

PMID:
21154142
8.

A review of vaccine research and development: the human immunodeficiency virus (HIV).

Girard MP, Osmanov SK, Kieny MP.

Vaccine. 2006 May 8;24(19):4062-81. Epub 2006 Feb 28. Review.

PMID:
16530298
9.

The past, present and future of HIV-vaccine development: a critical view.

Bojak A, Deml L, Wagner R.

Drug Discov Today. 2002 Jan 1;7(1):36-46. Review.

PMID:
11790602
10.

The expanding vaccine development pipeline, 1995-2008.

Davis MM, Butchart AT, Coleman MS, Singer DC, Wheeler JR, Pok A, Freed GL.

Vaccine. 2010 Feb 3;28(5):1353-6. doi: 10.1016/j.vaccine.2009.11.007. Epub 2009 Nov 21. Review.

PMID:
19932670
11.

Challenges to conducting HIV preventative vaccine trials with adolescents.

McClure CA, Gray G, Rybczyk GK, Wright PF.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):726-33. Review.

PMID:
15167292
12.

The development of HIV-1 subtype C vaccines for Southern Africa.

Williamson AL.

IUBMB Life. 2002 Apr-May;53(4-5):207-8. Review.

13.

A brief history of the global effort to develop a preventive HIV vaccine.

Esparza J.

Vaccine. 2013 Aug 2;31(35):3502-18. doi: 10.1016/j.vaccine.2013.05.018. Epub 2013 May 21. Review.

14.

Antituberculous vaccine development: a perspective for the endemic world.

Verma I, Grover A.

Expert Rev Vaccines. 2009 Nov;8(11):1547-53. doi: 10.1586/erv.09.111. Review.

PMID:
19863247
15.

30 years of AIDS vaccine research.

[No authors listed]

IAVI Rep. 2011 May-Jun;15(3):9-12. No abstract available.

16.

Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?

Esparza J, Bhamarapravati N.

Lancet. 2000 Jun 10;355(9220):2061-6. Review.

PMID:
10885368
17.

An HIV vaccine: how and when?

Esparza J.

Bull World Health Organ. 2001;79(12):1133-7.

18.

Cytokine adjuvants for vaccine therapy of neoplastic and infectious disease.

Decker WK, Safdar A.

Cytokine Growth Factor Rev. 2011 Aug;22(4):177-87. doi: 10.1016/j.cytogfr.2011.07.001. Epub 2011 Aug 20. Review.

PMID:
21862380
19.

[BCG vaccines for the prevention of tuberculosis in the world].

Hashimoto T.

Kekkaku. 1997 Nov;72(11):629-37. Japanese.

PMID:
9423301
20.

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.

Girard MP, Osmanov S, Assossou OM, Kieny MP.

Vaccine. 2011 Aug 26;29(37):6191-218. doi: 10.1016/j.vaccine.2011.06.085. Epub 2011 Jun 28. Review.

PMID:
21718747

Supplemental Content

Support Center